Psychemedics Corporation

OTCPK:PMDI Stock Report

Market Cap: US$11.1m

Psychemedics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Brian Hullinger

Chief executive officer

US$973.4k

Total compensation

CEO salary percentage12.9%
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenure1.4yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

Psychemedics Corporation's (NASDAQ:PMD) Shares Climb 37% But Its Business Is Yet to Catch Up

Dec 07
Psychemedics Corporation's (NASDAQ:PMD) Shares Climb 37% But Its Business Is Yet to Catch Up

Psychemedics Corporation's (NASDAQ:PMD) Prospects Need A Boost To Lift Shares

Jul 29
Psychemedics Corporation's (NASDAQ:PMD) Prospects Need A Boost To Lift Shares

There's Reason For Concern Over Psychemedics Corporation's (NASDAQ:PMD) Massive 28% Price Jump

Jan 08
There's Reason For Concern Over Psychemedics Corporation's (NASDAQ:PMD) Massive 28% Price Jump

Psychemedics (NASDAQ:PMD) Is Paying Out A Dividend Of $0.07

May 13
Psychemedics (NASDAQ:PMD) Is Paying Out A Dividend Of $0.07

Psychemedics GAAP EPS of -$0.06, revenue of $6.51M

Aug 09

Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play

Apr 25

Psychemedics: Q3 Revenues +29%, Margins Surge, Possible Corporate Actions Including Dividend

Nov 18

Psychemedics: Market Leader, 8% FCF Yield, Possible Takeover Target

Oct 18

Psychemedics reports Q1 results

May 10

We Think Psychemedics Corporation's (NASDAQ:PMD) CEO Compensation Package Needs To Be Put Under A Microscope

May 07
We Think Psychemedics Corporation's (NASDAQ:PMD) CEO Compensation Package Needs To Be Put Under A Microscope

Here's Why Psychemedics (NASDAQ:PMD) Can Afford Some Debt

Mar 05
Here's Why Psychemedics (NASDAQ:PMD) Can Afford Some Debt

Psychemedics Corp.: Trucking Along Into A Potential Big Catalyst ($21 PT)

Jan 30

How Much Are Psychemedics Corporation (NASDAQ:PMD) Insiders Spending On Buying Shares?

Jan 11
How Much Are Psychemedics Corporation (NASDAQ:PMD) Insiders Spending On Buying Shares?

Psychemedics reports Q3 results

Nov 09

CEO Compensation Analysis

How has Brian Hullinger's remuneration changed compared to Psychemedics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$3m

Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$973kUS$126k

-US$4m

Compensation vs Market: Brian's total compensation ($USD973.37K) is above average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Insufficient data to compare Brian's compensation with company performance.

CEO

Brian Hullinger (56 yo)

1.3yrs

Tenure

US$973,370

Compensation

Mr. Brian Hullinger serves as President, Chief Executive Officer and Director at Psychemedics Corporation since August 17, 2023. He served as Chief Revenue Officer at Cisive since 2018 until January 2023....

Leadership Team

NamePositionTenureCompensationOwnership
Brian Hullinger
President1.3yrsUS$973.37kno data
Daniella Mehalik
Vice President of Finance1.1yrsUS$126.41kno data
Shannon Shoemaker
VP & Chief Revenue Officer1.3yrsUS$386.62k0%
$ 0
Werner Baumgartner
Founder46.9yrsno datano data
Annette Baumgartner
Founder46.9yrsno datano data
Michael Weisenhoff
Principal Financial & Accounting Manager1.4yrsno datano data
Patrick Kinney
Secretaryno datano datano data

1.4yrs

Average Tenure

36yo

Average Age

Experienced Management: PMDI's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Brian Hullinger
President1.3yrsUS$973.37kno data
Darius Nevin
Independent Chairman2.3yrsUS$112.46k0.82%
$ 90.6k
Peter Kamin
Independent Director2.3yrsUS$112.46k10.23%
$ 1.1m
Andrew Reynolds
Independent Director2.7yrsUS$112.46k0.48%
$ 52.6k
Robyn Davis
Independent Director3.8yrsUS$112.46k0.66%
$ 73.3k

2.3yrs

Average Tenure

62yo

Average Age

Experienced Board: PMDI's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 05:11
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Psychemedics Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack WallaceSidoti & Company, LLC